Literature DB >> 19663811

Effects of different oocyte activation procedures on development and gene expression of porcine pre-implantation embryos.

R P Cervera1, M A Silvestre, N Martí, E García-Mengual, R Moreno, M Stojkovic.   

Abstract

Among the factors that affect the efficiency of somatic cell nuclear transfer (SCNT) in pigs, the activation protocol is the most variable among the current SCNT procedures. The aim of this study is focused on defining an efficient activation treatment of porcine oocytes. In Experiment 1, we studied the effects of nine different oocyte activation procedures (including chemical- and electrical-based treatments) on parthenogenetic embryo development. In Experiment 2, we studied the effect of the more efficient activation procedures on the gene expression profile of Oct4 and Igf2r in parthenogenetic blastocysts. In conclusion, ionomycin as a first calcium stimulus is not able to activate porcine oocytes efficiently in comparison with electric procedures. Electrical treatments with 6-DMAP significantly increased the level of Oct4 expression, whereas the single and double pulse treatments alone maintained the same profile as the IVF group.
© 2009 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19663811     DOI: 10.1111/j.1439-0531.2009.01509.x

Source DB:  PubMed          Journal:  Reprod Domest Anim        ISSN: 0936-6768            Impact factor:   2.005


  2 in total

1.  A simplified one-step nuclear transfer procedure alters the gene expression patterns and developmental potential of cloned porcine embryos.

Authors:  Sang Kyu Park; Sangho Roh; Jong-Im Park
Journal:  J Vet Sci       Date:  2013-06-30       Impact factor: 1.672

2.  An Improved System for Generation of Diploid Cloned Porcine Embryos Using Induced Pluripotent Stem Cells Synchronized to Metaphase.

Authors:  Eunhye Kim; Zhong Zheng; Yubyeol Jeon; Yong-Xun Jin; Seon-Ung Hwang; Lian Cai; Chang-Kyu Lee; Nam-Hyung Kim; Sang-Hwan Hyun
Journal:  PLoS One       Date:  2016-07-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.